Skip to main content

What does Item 3 reveal about a company's litigation and legal risks?

Every operating company faces legal risk. A customer sues for breach of contract. An employee sues for discrimination. A regulator investigates antitrust concerns. The EPA alleges environmental violations. A patent competitor challenges the company's patents. Most litigation does not rise to the level of disclosure in the 10-K, but material litigation — cases that could result in significant financial loss or reputational damage — must be disclosed.

Item 3 of the 10-K is where companies disclose material legal proceedings. The rule is: if a legal proceeding is material, the company must disclose it. Material means the litigation could result in financial loss exceeding a few million dollars (relative to the company's size), or the litigation raises questions about the company's conduct, product safety, or business model.

Item 3 is a window into the company's litigation exposure. But reading Item 3 requires care, because:

  1. Companies are incentivized to minimize litigation disclosure (to avoid scaring investors).
  2. Accruals for litigation are estimates, and estimates can be wrong.
  3. The absence of disclosure does not mean the company has no litigation; it means the company does not consider pending cases material.

This article walks through how to read Item 3, what kinds of litigation are typically disclosed, how to assess materiality, and what litigation disclosures signal about company risk.

Quick definition​

Item 3: Legal proceedings is the 10-K section where companies disclose material legal proceedings involving the company, its subsidiaries, or its directors and officers. Material litigation includes lawsuits, regulatory investigations, and government enforcement actions that could result in significant financial loss, criminal penalties, or operational restriction. Companies must also disclose any accruals (accounting reserves) for estimated litigation costs or settlements.

Key takeaways​

  1. Absence of Item 3 detail is not absence of litigation. Most companies experience ongoing litigation. The question is whether that litigation is material. An immaterial proceeding does not have to be disclosed.

  2. Materiality is subjective and disputed. The SEC believes many companies understate materiality to minimize disclosure. Companies that disclose minimal litigation might be accurately reporting immaterial cases or might be concealing material risks.

  3. Litigation accruals (reserves) are accounting estimates. The company estimates the probable cost of litigation and sets aside a reserve on the balance sheet. These estimates can be aggressive (too low) or conservative (too high). Auditors scrutinize litigation accruals heavily.

  4. Regulatory enforcement is separate from private litigation. A government investigation (by DOJ, SEC, EPA, FTC) is disclosed in Item 3 differently from a private lawsuit. Regulatory cases can result in fines, license restrictions, or criminal penalties.

  5. Aggregate materiality can exceed individual materiality. Even if no single case is material, if the company has dozens of similar cases (e.g., a product liability class action with multiple claimants), the aggregate exposure could be material.

  6. Litigation trends matter as much as current cases. A company with increasing litigation year-over-year is riskier than a company with stable litigation. Read Item 3 across multiple years to see trends.

The SEC requires disclosure of material litigation to inform investors of risks to the company. The definition of material litigation comes from the Regulation S-X rule 4-08(g), which requires disclosure of any legal proceedings that:

  1. Are pending or threatened, and
  2. Could result in financial loss material to the company, or
  3. Involve issues that the company considers material to its business.

Material is measured relative to the company's size and financial condition. A $10 million litigation judgment is material to a $100 million company but immaterial to a $100 billion company.

The challenge: companies determine materiality themselves. The SEC can challenge a company's materiality judgment, but enforcement is slow. Companies that systematically understate materiality might not be caught for years.

The auditor is required to audit the litigation accrual on the balance sheet. The auditor will review the company's litigation register, inquire of in-house counsel and outside counsel, and assess whether the accrual is adequate. If the auditor believes a material case has not been accrued or disclosed, the auditor would challenge the financial statements.

Product liability litigation. A customer uses the company's product, is injured or harmed, and sues. Example: A pharmaceutical company discloses litigation from patients claiming a drug caused side effects. A car manufacturer discloses lawsuits from accidents involving vehicles with alleged defects.

Employment litigation. An employee or group of employees sues the company for discrimination, wage and hour violations, wrongful termination, or harassment. Class actions (where many employees file together) are particularly material because the exposure is large.

Example Item 3 language: "We are party to litigation filed by former employees alleging wage and hour violations in California. The action is pending in state court; we have accrued $5 million for estimated settlement costs."

Intellectual property disputes. A competitor or patent troll alleges that the company's product infringes their patent. The company might also assert that their own patents are invalid. Patent litigation is complex and expensive (often $5-20 million per case to litigate through trial).

Antitrust and competition issues. The Federal Trade Commission or Department of Justice alleges the company is engaging in anticompetitive behavior (price-fixing, exclusive dealing, monopolistic abuse). These cases are rare but very material when they occur.

Environmental litigation. A community, environmental group, or regulator alleges the company has polluted land or water. Example: A petrochemical company discloses litigation over soil contamination at a former facility.

Breach of contract. A customer or supplier sues for non-performance on a contract. These are usually smaller and less frequently disclosed unless material.

Regulatory enforcement. The SEC, FBI, FTC, EPA, or another regulator investigates or prosecutes the company. Example: The SEC investigates accounting practices; the EPA alleges environmental violations; the FDA issues a warning letter about manufacturing practices.

Securities litigation. Shareholders sue the company for securities fraud (claiming management misled investors). This is particularly common after a stock decline, with investors alleging the company did not disclose material negative information.

Tax disputes. The IRS or state tax authority disputes the company's tax position and assesses additional taxes and penalties.

A mermaid diagram: litigation disclosure process​

Understanding materiality in litigation disclosure​

Materiality in litigation is measured several ways:

Quantitative materiality:

  • Is the potential loss (in dollars) large relative to company earnings? A $50 million litigation exposure is material to a company with $100 million net income but immaterial to a company with $10 billion net income.

  • Materiality threshold: Most large companies consider 5-10 percent of annual net income as the threshold for quantitative materiality. So a $500 million company with $100 million net income would consider $5-10 million litigation material.

Qualitative materiality:

  • Does the litigation raise questions about the company's core business model or product safety? A litigation case raising serious product safety questions might be material even if the estimated financial loss is small.

  • Is the litigation part of a pattern? One customer complaint is immaterial; 100 similar complaints are material, even if individually small.

  • Does the litigation raise regulatory or compliance questions? Litigation suggesting the company violated environmental law or securities law is material because it signals broader compliance risk.

Reputational materiality:

  • Would investors want to know about this litigation? Litigation that could damage the company's brand or public perception is material.

Example: A pharmaceutical company settles a product liability case with a confidentiality clause. Even if the settlement amount is immaterial (a few million dollars), the litigation might be material because it raises product safety questions. Item 3 would require disclosure of the product liability claim (though the settlement amount might not be specified if confidentiality applies).

Reading Item 3 for signal​

No legal proceedings disclosed. This means either the company is litigation-free (rare) or the company has determined all current litigation is immaterial. Most mature companies have ongoing litigation.

A company with zero litigation disclosure is either:

  • Very small or new (less exposure),
  • Exceptionally well-run with no litigation (rare),
  • Concealing material litigation (possible, especially for smaller or less transparent companies).

General categories disclosed with no specific cases. Example: "We are party to various legal proceedings that arise in the ordinary course of business, including product liability claims, employment disputes, and contract disagreements. We do not believe any of these proceedings, individually or in aggregate, are material to our financial position."

This is boilerplate and signals the company has ongoing routine litigation but nothing it considers material. This is normal.

Specific cases disclosed with estimated financial exposure. Example: "We are party to a class action lawsuit in California state court alleging wage and hour violations. The case encompasses approximately 5,000 former and current employees. Based on legal counsel's assessment, we have accrued $25 million for estimated settlement of this matter. The case is expected to resolve in 2025."

This is material litigation. The company has estimated the cost ($25 million), accrued it on the balance sheet, and disclosed it. Investors can see the financial impact.

Cases disclosed with no accrual and uncertain exposure. Example: "We are the subject of a civil investigation by the Federal Trade Commission regarding alleged anticompetitive practices in our distribution system. We are cooperating with the investigation and cannot predict its outcome. While an adverse judgment is possible, we cannot reasonably estimate a range of potential loss at this time."

This signals material but highly uncertain litigation. The company has not accrued a reserve because the outcome is too uncertain. But investors are aware the company faces a significant regulatory risk.

Real-world examples of Item 3 analysis​

Example 1: A pharmaceutical company's product liability litigation. The company disclosed in Item 3: "We are defending product liability litigation in multiple jurisdictions related to [Drug Name]. As of December 31, 2024, there are approximately 2,500 pending claims. We have accrued $150 million for estimated settlement and defense costs. The claims allege [health condition] resulting from use of [Drug Name]. We believe the litigation will be resolved through settlement over 18 months."

What this reveals: (1) The company has a product that is generating litigation. (2) The exposure is large (2,500 claims, $150 million accrual). (3) The company expects settlement, not trial. (4) The company is prepared financially for the exposure. As an investor, you would note that future earnings could face a $150 million charge if the reserve is released. You would also monitor whether the number of claims is increasing or decreasing (trend matters).

Example 2: A financial services company's regulatory investigation. The company disclosed in Item 3: "The SEC is conducting an investigation into certain of our sales practices regarding [Product Category]. We are cooperating with the SEC. We cannot predict the outcome or estimate potential exposure at this time. Possible outcomes include fines, remediation of customer accounts, or restrictions on future sales of the product. An unfavorable outcome could be material to our financial condition."

What this reveals: (1) The SEC is investigating. This is serious. (2) The company has not accrued anything because the outcome is truly uncertain. (3) Possible outcomes range from modest fines to significant restrictions. Investors should be concerned because the upside is capped at resolution, but the downside is open-ended.

Example 3: An employment litigation trend. A company with a history of low employment litigation disclosure suddenly discloses in Item 3: "We are party to an increasing number of employment litigation matters, including wage and hour class actions in California and New York, sexual harassment claims, and discrimination allegations. We have accrued $50 million for estimated settlement of these matters. The number of claims is increasing at approximately 10 percent annually."

What this reveals: (1) There is a trend toward more litigation. This is a warning sign about workplace culture or management. (2) The company is proactively accruing, which is good. (3) But the trend suggests the problem is not being resolved; it is getting worse. Investors should ask: What is driving this increase?

Example 4: A small company with minimal litigation disclosure. A small-cap company discloses in Item 3: "We are aware of no pending or threatened legal proceedings that we consider material."

What this reveals: Either the company is early-stage and low-risk, or the company is not sophisticated about materiality assessment. For a small company, a $1 million litigation matter might be material (5-10 percent of net income). If the company is claiming zero material litigation, either it is very clean or it is underreporting.

Accruals and accounting estimates​

When a litigation case is material and the probable outcome and amount are reasonably estimable, the company accrues a reserve on the balance sheet. The accrual is an accounting estimate, meaning:

  1. The estimate could be wrong. The settlement could be higher or lower than accrued.

  2. The auditor audits the estimate. The auditor inquires of in-house and outside counsel about the probability and range of settlement. The auditor challenges any estimate that seems aggressive (too low) or inconsistent with past settlements.

  3. Subsequent settlement could be a gain or loss. If a case is accrued at $10 million and settles for $8 million, the company records a $2 million gain in the period of settlement (reversing part of the accrual). If it settles for $12 million, the company records a $2 million loss (additional accrual).

  4. Management incentive exists to underestimate. Lower litigation accruals result in higher reported earnings. Investors should be skeptical of companies that consistently report litigation accruals that are later found to be too low.

Litigation accruals appear in the balance sheet (under Current Liabilities or Non-Current Liabilities, often labeled "Accrued Litigation" or "Contingent Liabilities") and in the notes to the financial statements (Note on Commitments and Contingencies).

The role of counsel letters​

During the audit, the auditor requests letters from the company's outside counsel (law firms) disclosing all pending or threatened litigation. These counsel letters are confidential; they do not appear in the 10-K. But they inform the auditor's assessment of Item 3 disclosure and litigation accruals.

Counsel letters can reveal:

  • Cases the company might not have disclosed in Item 3 (raising questions about management's materiality judgment),
  • Counsel's estimates of settlement ranges or probability,
  • Cases management views as immaterial but counsel views as material.

If the auditor sees a significant gap between counsel's assessment and management's disclosure, the auditor will challenge the 10-K disclosure and accruals.

Historical trend: In the 1980s-1990s, companies routinely under-disclosed litigation. The SEC in the 2000s began enforcing Item 3 more aggressively, requiring more complete disclosure. By the 2010s, Item 3 disclosure had expanded significantly.

Recent trend: Post-2020, litigation has evolved:

  • Employment litigation surge: Particularly wage and hour class actions and discrimination claims. This is driven by more aggressive plaintiffs' attorneys and increased employee awareness.

  • Environmental litigation. As environmental liability becomes more material (climate change, PFOA contamination, etc.), environmental litigation disclosure has expanded.

  • Antitrust litigation. Big Tech companies now routinely disclose antitrust litigation and government investigations. This is relatively new and reflects increased regulatory scrutiny.

  • Securities class actions. After significant stock declines, securities class actions are nearly automatic. Companies disclose these routinely, though many are dismissed or settled for insurance.

Common mistakes when reading Item 3​

Mistake 1: Assuming no litigation disclosure means no litigation. Many companies with routine litigation do not disclose it because they consider it immaterial. Item 3 is not a complete litigation inventory; it is a materiality filter.

Mistake 2: Over-weighting a single disclosed case. A company discloses one material litigation case and an investor assumes the company is doomed. But one case is material only if it is large relative to the company's earnings. For a large company, a $100 million litigation exposure might be a 5 percent hit to annual earnings — material but not disqualifying.

Mistake 3: Not reading accrual detail in the notes. Item 3 discloses the case; the financial statement notes disclose the accrual. Always read both. The accrual often has more detail.

Mistake 4: Failing to assess litigation trends. A company with stable litigation year-over-year is normal. A company with increasing litigation is a warning sign. Always read Item 3 across multiple years to see trends.

Mistake 5: Confusing probability assessment. The SEC requires accrual if loss is "probable and estimable." Probable means more than 50 percent likelihood. If counsel says the likelihood is 45 percent, no accrual is required (though disclosure is). As an investor, understand the probability assessment is management's judgment and could be wrong.

Mistake 6: Ignoring regulatory enforcement. If Item 3 discloses a government investigation (SEC, DOJ, EPA, FTC), this is serious. Regulatory enforcement can result in major fines, license restrictions, or criminal charges. Give it more weight than private litigation.

Mistake 7: Not considering aggregate exposure. Item 3 might list dozens of product liability claims individually. The company might argue each claim is immaterial, but the aggregate could be material. Read Item 3 carefully to assess aggregate exposure, not just individual cases.

Frequently asked questions​

Q: If a company settles litigation, when is it disclosed?

A: Settlement is typically disclosed in the period in which it is settled. The company reverses (adjusts) any accrual, with the net effect (gain or loss) recorded in earnings. If the settlement is material, it might also trigger an 8-K filing (if the 8-K materiality threshold is crossed). Item 3 in the next 10-K will show the case as resolved.

Q: Why do some litigation cases have confidentiality agreements that prevent disclosure of the settlement amount?

A: Plaintiffs' attorneys often negotiate confidentiality clauses as part of settlement. The company agrees not to disclose the amount paid. Confidentiality protects the plaintiff from copycat lawsuits and protects the company from setting a precedent that suggests high settlement values. But the company must still disclose that litigation occurred in Item 3 and must estimate the accrual for the auditor, even if the settlement amount is confidential.

Q: Can litigation disclosure in Item 3 move the stock price?

A: Yes, if the litigation is material and was previously unknown to the market. A company that discloses a $500 million environmental liability in Item 3 has signaled a material risk. Stock price typically falls on that news. But if the litigation was previously disclosed (e.g., in a prior 10-K), including it again in Item 3 does not surprise the market.

Q: What is the difference between a "pending" and "threatened" litigation?

A: Pending litigation is already filed in court. Threatened litigation is not yet filed but appears likely to be filed. A company discloses both. A threatened case that has not been filed yet must be disclosed if it is material and the threat is credible.

Q: If Item 3 discloses "various legal proceedings," does that mean there are many undisclosed cases?

A: It means the company has routine litigation but none individually material. This is normal boilerplate. However, if the aggregate of immaterial cases is material, the company should disclose that aggregate exposure. Some companies provide aggregate categories: "Product liability claims, individually immaterial but totaling $15 million accrued."

Q: Can an investor sue if Item 3 omits material litigation?

A: Theoretically yes. If a company failed to disclose material litigation and that failure affected an investor's decision to buy or hold the stock, the investor might have a securities fraud claim. But in practice, such suits are difficult to win because the company was likely not intentionally misleading; it was exercising materiality judgment.

Q: How does litigation affect the valuation of a company?

A: Large litigation exposure reduces the company's value. If the company has accrued the reserve, the balance sheet and earnings are already adjusted for the expected cost. If litigation is disclosed but not accrued (because outcome is uncertain), investors must estimate the probability and impact themselves, which is harder. Some investors discount future cash flows for litigation risk; others simply subtract the litigation exposure from enterprise value.

Contingent liabilities. Liabilities that are probable but uncertain in amount. Item 3 litigation is the most common source of contingent liability disclosures.

Litigation accrual (reserve). The balance sheet liability set aside to cover estimated litigation costs. Found under Current or Non-Current Liabilities.

Commitments and contingencies note. The financial statement note providing detail on litigation, environmental liabilities, and other contingencies.

Audit procedures for litigation. The auditor's inquiry process (counsel letters, management inquiries, documentation review) to assess litigation disclosure completeness.

Securities class action. Litigation by shareholders alleging the company (or its officers) made false statements that harmed investor returns. Very common after stock declines.

Regulatory enforcement. Government investigation or prosecution by SEC, DOJ, EPA, FTC, etc. More serious than private litigation because outcomes can include fines and operating restrictions.

Summary​

Item 3 discloses material legal proceedings that could affect the company's financial condition or operations. Understanding Item 3 requires assessing:

  1. Materiality. Is the litigation large enough to matter for your investment decision? Relative to company size?

  2. Accrual completeness. Has the company properly estimated and reserved for the litigation cost? Has the auditor signed off?

  3. Trend analysis. Is litigation increasing, stable, or decreasing? Trends reveal underlying management or operational issues.

  4. Probability and outcome. What is the likelihood of an unfavorable judgment? What is the estimated range of loss?

  5. Regulatory dimension. Is the litigation private (customer or employee lawsuit) or regulatory (government investigation)? Regulatory cases are more serious.

  6. Aggregate exposure. Even if no single case is material, does the aggregate litigation portfolio pose material risk?

Item 3 is not a complete litigation inventory. It is management's judgment of what is material to investors. Be skeptical of companies that claim minimal litigation without explaining why (especially in industries like pharma, auto, or employment-intensive sectors where litigation is common). But do not over-weight a single disclosed case without understanding its context and size relative to the company.

Next​

In the next article, we examine Item 4 of the 10-K, which addresses mine safety disclosures and their unique regulatory origin.

→ Item 4: Mine safety disclosures